Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

被引：0
|
作者：
Michiyasu Murakami
Hiroki Hashimoto
Kyohei Yamaguchi
Ikuko Yamaguchi
Shozo Senba
Takeshi Siraishi
机构：
[1] Matsuyama Red Cross Hospital,Department of Pharmacy
[2] Matsuyama Red Cross Hospital,Department of Nursing
[3] Matsuyama Red Cross Hospital,Department of Gastrointestinal Surgery
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Antiemesis; Gastrointestinal cancer; Moderately emetogenic chemotherapy; Palonosetron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：905 / 909
页数：4
相关论文
共 50 条
  • [31] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting
    Mori-Vogt, Sherry
    Blazer, Marlo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (08) : 919 - 936
  • [32] Palonosetron for the treatment of chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2599 - 2608
  • [33] Optimal prophylaxis of chemotherapy-induced nausea and vomiting for moderately emetogenic chemotherapy: a meta-analysis
    Zhang, Yaxiong
    Hou, Xue
    Zhang, Rong
    Chen, Gang
    Huang, Yan
    Yang, Yunpeng
    Zhao, Yuanyuan
    Fang, Wenfeng
    Hong, Shaodong
    Kang, Shiyang
    Zhou, Ting
    Zhang, Zhonghan
    Chen, Xi
    Zhang, Li
    FUTURE ONCOLOGY, 2018, 14 (19) : 1933 - 1941
  • [34] Phase III study of palonosetron for preventing chemotherapy-induced nausea and vomiting in pediatric patients
    Koga, Yuhki
    Kosaka, Yoshiyuki
    Koh, Katsuyoshi
    Matsumoto, Kimikazu
    Kumamoto, Tadashi
    Fujisaki, Hiroyuki
    Ishida, Yuji
    Suzuki, Ryoko
    Mochizuki, Shinji
    Goto, Hiroaki
    Yuza, Yuki
    Hara, Junichi
    ANNALS OF ONCOLOGY, 2021, 32 : S284 - S284
  • [35] Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gastrointestinal cancers receiving moderately emetogenic chemotherapy regimens
    Cindy, Weinstein
    Karin, Jordan
    Stuart, Green
    Saleem, Khanani
    Elizabeth, Beckford-Brathwaite
    Waldimir, Vallejos
    Annpey, Pong
    Stephen, Noga
    Bernardo, Rapoport
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
    Aapro, M. S.
    Grunberg, S. M.
    Manikhas, G. M.
    Olivares, G.
    Suarez, T.
    Tjulandin, S. A.
    Bertoli, L. F.
    Yunus, F.
    Morrica, B.
    Lordick, F.
    Macciocchi, A.
    ANNALS OF ONCOLOGY, 2006, 17 (09) : 1441 - 1449
  • [37] Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy
    Celio, Luigi
    Agustoni, Francesco
    Testa, Isabella
    Dotti, Katia
    de Braud, Filippo
    TUMORI JOURNAL, 2012, 98 (03): : 279 - 286
  • [38] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
    Miya, Toshimichi
    Kobayashi, Kunihiko
    Hino, Mitsunori
    Ando, Masahiro
    Takeuchi, Susumu
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    SPRINGERPLUS, 2016, 5
  • [39] Olanzapine and palonosetron without dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: A proof-of-concept trial.
    Kim, Hee Jun
    Ha, Joo Young
    Oh, Edward Hyunseung
    Park, Song Ee
    Yi, Jun Ho
    Jang, Joung Soon
    Hwang, In Gyu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Effectiveness of Antiemetics in the Management of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Following Chemotherapy Guidelines
    Kandasamy, Geetha
    Sivanandy, P.
    Khobrani, M.
    Almaghaslah, Dalia
    Almanasef, Mona
    Vasudevan, Rajalakshimi
    Chinnadhurai, Maheswari
    Honey, Nayana
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (04) : 757 - 765
12345